GeneBioTech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GeneBioTech Co Ltd

Watchlist Manager

Watchlist

Price: 4 865 KRW -0.31%

Market Cap: ₩41.9B

G	GeneBioTech Co Ltd KOSDAQ:086060	KR
	Transcorp International Ltd BSE:532410	IN
	ValiRx PLC LSE:VAL	UK
G	Gifu Landscape Architect Co Ltd TSE:1438	JP
	Nicolas Correa SA MAD:NEA	ES
	Reenova Investment Holding Ltd SGX:5EC	SG
	Ministop Co Ltd TSE:9946	JP
S	San Miguel Food and Beverage Inc XPHS:FB	PH
	Signpost Corp TSE:3996	JP
S	Svitzer Group A/S CSE:SVITZR	DK
	First Mining Gold Corp TSX:FF	CA
	Compania Espanola de Viviendas en Alquiler SA MAD:CEV	ES
A	Adtran Networks SE XMUN:ADV	DE
N	Ningbo Ocean Shipping Co Ltd SSE:601022	CN
T	TuanChe Ltd NASDAQ:TC	CN
V	Viet Nam Medicinal Materials JSC VN:DVM	VN

Profitability Summary

GeneBioTech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

16%

Gross Margin is Increasing

15% > 17%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

4% > 5%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.